CompletedNot Applicable

Study of Anemia in Chronic Kidney Disease (CKD) Among High-Risk Hypertensive and Diabetic Patients in Pakistan

Pakistan246 participantsStarted 2011-05

Plain-language summary

The purpose of this study is to evaluate the prevalence of CKD-related anemia at an early stage through screening of high-risk patients in Pakistan at the level of physicians, cardiologists, and diabetologists. The information gathered may serve as a foundation in formulating national guidelines for better early diagnosis and management of patients with CKD.

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age greater than or equal to 40 years * Known hypertension and/or diabetes for at least 3 years * Positive dipstick test result for proteinuria Exclusion Criteria: * Known CKD * Receiving erythropoietin * Blood transfusion within 8 weeks * History of acute or chronic bleeding, hemolysis, or hemoglobinopathy

What they're measuring

Number of patients with anemia secondary to CKD

Timeframe: Up to 12 months

Trial details

NCT IDNCT02444845

SponsorHoffmann-La Roche

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2012-08

View on ClinicalTrials.gov More Anemia, Diabetes, Kidney Disease, Chronic, Hypertension trials